Bio

Mr. Blank has gathered extensive experience investing in publicly traded life sciences companies and conducting scientific, clinical, regulatory, and financial diligence throughout his time at Aspire Capital. Prior to joining Aspire Capital, he worked as Summer Associate within the healthcare investment banking group at National Securities Corp. Mr. Blank began his career in biotechnology as an Associate at Integrated Genomics, Inc. where he conducted research, including antimicrobial drug target discovery, and supported business development initiatives targeting large pharmaceutical companies and academic institutions. He earned a B.S. in Molecular and Cellular Biology from the University of Illinois and a M.S. in Biotechnology from Johns Hopkins University. Mr. Blank also holds the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society of Chicago.